Publication

Hydrogen sulfide cytoprotective signaling is endothelial nitric oxide synthase-nitric oxide dependent

Downloadable Content

Persistent URL
Last modified
  • 03/05/2025
Type of Material
Authors
    Adrienne King, Emory UniversityDavid J. Polhemus, Louisiana State UniversityShashi Bhushan, Louisiana State UniversityHiroyuki Otsuka, Louisiana State UniversityKazuhisa Kondo, Emory UniversityChad K. Nicholson, Emory UniversityJessica M. Bradley, Louisiana State UniversityKazi N. Islam, Louisiana State UniversityJohn Calvert, Emory UniversityYa-Xiong Tao, Auburn UniversityTammy R. Dugas, Louisiana State UniversityEric E. Kelley, University of PittsburghJohn W. Elrod, Temple UniversityPaul L. Huang, Massachusetts General HospitalRui Wang, Lakehead UniversityDavid J. Lefer, Louisiana State University
Language
  • English
Date
  • 2014-02-25
Publisher
  • National Academy of Sciences
Publication Version
Copyright Statement
  • © 2014 National Academy of Sciences
Final Published Version (URL)
Title of Journal or Parent Work
ISSN
  • 0027-8424
Volume
  • 111
Issue
  • 8
Start Page
  • 3182
End Page
  • 3187
Grant/Funding Information
  • This work was supported by Grants from the National Heart, Lung, and Blood Institute (1R01 HL092141, 1R01 HL093579, 1U24 HL 094373, and 1P20 HL113452 to D.J.L., and 5R01 HL 098481 to J.W.C.).
  • We are also grateful for the generous financial support from the Carlyle Fraser Heart Center of Emory University and the Louisiana State University Health Foundation in New Orleans.
  • These studies were also supported by the Canadian Institutes of Health Research (R.W.).
Supplemental Material (URL)
Abstract
  • Previous studies have demonstrated that hydrogen sulfide (H 2 S) protects against multiple cardiovascular disease states in a similar manner as nitric oxide (NO). H 2 S therapy also has been shown to augment NO bioavailability and signaling. The purpose of this study was to investigate the impact of H 2 S deficiency on endothelial NO synthase (eNOS) function, NO production, and ischemia/reperfusion (I/R) injury. We found that mice lacking the H 2 S-producing enzyme cystathionine γ-lyase (CSE) exhibit elevated oxidative stress, dysfunctional eNOS, diminished NO levels, and exacerbated myocardial and hepatic I/R injury. In CSE KO mice, acute H 2 S therapy restored eNOS function and NO bioavailability and attenuated I/R injury. In addition, we found that H 2 S therapy fails to protect against I/R in eNOS phosphomutant mice (S1179A). Our results suggest that H 2 S-mediated cytoprotective signaling in the setting of I/R injury is dependent in large part on eNOS activation and NO generation.
Author Notes
Keywords
Research Categories
  • Health Sciences, Medicine and Surgery
  • Health Sciences, Pharmacology

Tools

Relations

In Collection:

Items